Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in AXGN — Axogen, Inc.

CIK 1423053 MIAMI, FL
Back to AXGN Full portfolio

Position in AXGN

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$62,856,783
+$54,738,145 QoQ
Shares Held
1,360,831
+455.3% QoQ
Ownership
2.53%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#9
of 253 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AXGN Over Time

Shares Held

Position Value (USD)

Derivatives in AXGN

reported options exposure · as of Jun 30, 2026
CallValue
$434,186
CallShares
9,400
PutValue
$351,044
PutShares
7,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $3,553,993,098 across 97 Medical Devices names. AXGN ranks #15 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 8,597,227 $780,112,377
2 MDT
Medtronic plc
 5,373,877 $420,398,397
3 EW
Edwards Lifesciences Corp
 3,997,925 $361,652,295
4 ZBH
Zimmer Biomet Holdings, Inc.
 3,477,472 $299,375,563
5 BSX
Boston Scientific Corp
 4,987,748 $212,877,084
6 GKOS
GLAUKOS Corp
 1,390,017 $194,268,775
7 GEHC
GE HealthCare Technologies Inc.
 2,367,032 $151,513,717
8 PEN
Penumbra Inc
 448,763 $141,696,917

All Filings in AXGN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $62,856,783 1,360,831
2026-06-30 $434,186 9,400
2026-06-30 $351,044 7,600
2026-03-31 $327,987 9,900
2026-03-31 $8,118,638 245,054
2025-12-31 $4,867,736 148,724
2025-12-31 $288,024 8,800
2025-09-30 $581,584 32,600
2025-09-30 $790,454 44,308
2025-06-30 $207,235 19,100
2025-03-31 $817,700 44,200
2025-03-31 $3,775,942 204,105
2025-03-31 $247,900 13,400
2024-12-31 $73,120 4,437
2024-12-31 $18,128 1,100
2024-12-31 $568,560 34,500
2024-09-30 $118,384 8,444
2024-09-30 $5,608 400
2024-09-30 $360,314 25,700
2024-06-30 $290,324 40,100
2024-06-30 $579,366 80,023
2024-06-30 $3,620 500
2024-03-31 $328,449 40,700
2024-03-31 $26,631 3,300
2023-12-31 $229,473 33,598
2023-12-31 $23,222 3,400
2023-12-31 $14,343 2,100
2023-09-30 $111,000 22,200
2023-09-30 $378,140 75,628
2023-09-30 $12,000 2,400
2023-06-30 $14,608 1,600
2023-06-30 $712,140 78,000
2023-06-30 $1,134,968 124,312
2023-03-31 $23,625 2,500
2023-03-31 $2,118,746 224,206
2023-03-31 $1,094,310 115,800
2022-12-31 $116,766 11,700
2022-12-31 $583,830 58,500
2022-12-31 $2,533,762 253,884
2022-09-30 $412,432 34,600
2022-09-30 $134,696 11,300
2022-09-30 $324,211 27,199
2022-06-30 $715,806 87,400
2022-06-30 $1,719,515 209,953
2022-03-31 $134,980 17,000
2022-03-31 $3,297,648 415,321
2022-03-31 $1,241,022 156,300
2021-12-31 $139,613 14,900
2021-12-31 $2,998,362 319,996
2021-12-31 $719,616 76,800